BenevolentAI’s co-founder is back. Here’s how he plans a turnaround at the AI company during a ‘pivotal time’

Can Ken Mul­vany save Benev­o­len­tAI?

About a decade ago, Mul­vany helped found the com­pa­ny as part of the first gen­er­a­tion of AI-fo­cused biotech star­tups. It …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Long Q4 Lifts Organigram Revenue

Organigram Reports Fiscal 2023 Results¹ Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to

Read More »